N‑methyl‑D‑aspartate receptor antagonist MK‑801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection

  • Authors:
    • Qiang Zhang
    • Yang Shao
    • Changsong Zhao
    • Juan Cai
    • Sheng Sun
  • View Affiliations

  • Published online on: October 17, 2014     https://doi.org/10.3892/etm.2014.2029
  • Pages: 1731-1736
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Spinal cord injury is the main cause of paraplegia, but effective therapies for it are lacking. Embryonic spinal cord transplantation is able to repair spinal cord injury, albeit with a large amount of neuronal apoptosis remaining in the spinal cord. MK‑801, an N‑methyl‑D‑aspartate (NMDA) receptor antagonist, is able to reduce cell death by decreasing the concentration of excitatory amino acids and preventing extracellular calcium ion influx. In this study, the effect of MK‑801 on the apoptosis of spinal cord neurons in rats that have received a fetal spinal cord (FSC) transplant following spinal hemisection was investigated. Wistar rats were divided into three groups: Spinal cord hemisection injury with a combination of FSC transplantation and MK‑801 treatment (group A); spinal cord hemisection injury with FSC transplantation (group B); and spinal cord injury with insertion of a Gelfoam pledget (group C). The rats were sacrificed 1, 3, 7 and 14 days after the surgery. Apoptosis in spinal slices from the injured spinal cord was examined by terminal deoxynucleotidyl transferase‑mediated dUTP‑biotin nick end labeling reaction, and the expression of B‑cell lymphoma‑2 (Bcl‑2) was measured by immunohistochemistry. The positive cells were quantitatively analyzed using a computer image analysis system. The rate of apoptosis and the positive expression of Bcl‑2 protein in the spinal cord neurons in the three groups decreased in the following order: C>B>A (P<0.05) and A>B>C (P<0.05), respectively. This indicates that treatment with the NMDA receptor antagonist MK‑801 prevents apoptosis in the spinal cord neurons of rats that have undergone FSC transplantation following spinal hemisection.
View Figures
View References

Related Articles

Journal Cover

December-2014
Volume 8 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Shao Y, Zhao C, Cai J and Sun S: N‑methyl‑D‑aspartate receptor antagonist MK‑801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection. Exp Ther Med 8: 1731-1736, 2014
APA
Zhang, Q., Shao, Y., Zhao, C., Cai, J., & Sun, S. (2014). N‑methyl‑D‑aspartate receptor antagonist MK‑801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection. Experimental and Therapeutic Medicine, 8, 1731-1736. https://doi.org/10.3892/etm.2014.2029
MLA
Zhang, Q., Shao, Y., Zhao, C., Cai, J., Sun, S."N‑methyl‑D‑aspartate receptor antagonist MK‑801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection". Experimental and Therapeutic Medicine 8.6 (2014): 1731-1736.
Chicago
Zhang, Q., Shao, Y., Zhao, C., Cai, J., Sun, S."N‑methyl‑D‑aspartate receptor antagonist MK‑801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection". Experimental and Therapeutic Medicine 8, no. 6 (2014): 1731-1736. https://doi.org/10.3892/etm.2014.2029